Skip to content

Clinical trials

Completed Macular Degeneration trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Macular Degeneration Status: Completed Country / region: South Korea Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20072
20083
20092
20104
20112
20132
20141
20151
20161
20183
20192
20203
20211
20222
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed31

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
Allergan3
Kim's Eye Hospital3
Kyungpook National University Hospital3
Bayer2
Novartis2
Amgen1
AngioLab, Inc.1
Chong Kun Dang Pharmaceutical1
EyebioKorea, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Macular Degeneration31
Choroidal Neovascularization8
Polypoidal Choroidal Vasculopathy4
Vision Disorders3
Eye Diseases2
Geographic Atrophy2
Retinal Diseases2
Retinal Vein Occlusion2
Wet Macular Degeneration2
Blindness1

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.